Umesan UK et al. |
Assessing salivary biomarkers for analyzing orthodontic tooth movement. |
2013 |
Am J Orthod Dentofacial Orthop |
pmid:23561400
|
Flórez-Moreno GA et al. |
Authors' response. |
2013 |
Am J Orthod Dentofacial Orthop |
pmid:23561401
|
Low E et al. |
Expression of mRNA for osteoprotegerin and receptor activator of nuclear factor kappa beta ligand (RANKL) during root resorption induced by the application of heavy orthodontic forces on rat molars. |
2005 |
Am J Orthod Dentofacial Orthop |
pmid:16214633
|
Taddei SR et al. |
Role of CCR2 in orthodontic tooth movement. |
2012 |
Am J Orthod Dentofacial Orthop |
pmid:22284282
|
Yabumoto T et al. |
Stabilization of tooth movement by administration of reveromycin A to osteoprotegerin-deficient knockout mice. |
2013 |
Am J Orthod Dentofacial Orthop |
pmid:23992809
|
Zhao N et al. |
Local osteoprotegerin gene transfer inhibits relapse of orthodontic tooth movement. |
2012 |
Am J Orthod Dentofacial Orthop |
pmid:22196183
|
Galli C et al. |
Effect of surface treatment on cell responses to grades 4 and 5 titanium for orthodontic mini-implants. |
2012 |
Am J Orthod Dentofacial Orthop |
pmid:22640672
|
Kuczkowski J et al. |
Expression of the receptor activator for nuclear factor-κB ligand and osteoprotegerin in chronic otitis media. |
2010 Nov-Dec |
Am J Otolaryngol |
pmid:20015790
|
Røysland R et al. |
Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial. |
2010 |
Am. Heart J. |
pmid:20691834
|
Mogelvang R et al. |
Comparison of osteoprotegerin to traditional atherosclerotic risk factors and high-sensitivity C-reactive protein for diagnosis of atherosclerosis. |
2012 |
Am. J. Cardiol. |
pmid:22100028
|
Akat K et al. |
Calcium metabolism in adults with severe aortic valve stenosis and preserved renal function. |
2010 |
Am. J. Cardiol. |
pmid:20211333
|
Dahl JS et al. |
Relation of osteoprotegerin in severe aortic valve stenosis to postoperative outcome and left ventricular function. |
2013 |
Am. J. Cardiol. |
pmid:23871267
|
Abedin M et al. |
Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study). |
2007 |
Am. J. Cardiol. |
pmid:17293196
|
Schnabel RB et al. |
Relation of multiple inflammatory biomarkers to incident atrial fibrillation. |
2009 |
Am. J. Cardiol. |
pmid:19576326
|
Erkol A et al. |
Relation of circulating osteoprotegerin levels on admission to microvascular obstruction after primary percutaneous coronary intervention. |
2011 |
Am. J. Cardiol. |
pmid:21247537
|
Van Campenhout A et al. |
Serum osteoprotegerin as a biomarker for vascular disease. |
2007 |
Am. J. Cardiol. |
pmid:17659953
|
Shen C et al. |
Relation between bone mineral density, bone loss and the risk of cardiovascular disease in a Chinese cohort. |
2012 |
Am. J. Cardiol. |
pmid:22762713
|
Shea MK et al. |
Vitamin K supplementation and progression of coronary artery calcium in older men and women. |
2009 |
Am. J. Clin. Nutr. |
pmid:19386744
|
Shea MK et al. |
Vitamin K, circulating cytokines, and bone mineral density in older men and women. |
2008 |
Am. J. Clin. Nutr. |
pmid:18689371
|
Roux S et al. |
RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone. |
2002 |
Am. J. Clin. Pathol. |
pmid:11863217
|
Sato T et al. |
Interleukin-11 as an osteoprotegerin-inducing factor in culture medium of blastic cells from a patient with acute megakaryocytic leukemia complicated with osteosclerosis. |
2004 |
Am. J. Hematol. |
pmid:15307108
|
Elhasid R et al. |
Familial severe congenital neutropenia associated with infantile osteoporosis: a new entity. |
2003 |
Am. J. Hematol. |
pmid:12508266
|
Nuño-Arana I et al. |
Distribution of three SNPs related to low bone mineral density in Amerindian groups and Mestizos from Mexico. |
2012 Jul-Aug |
Am. J. Hum. Biol. |
pmid:22434650
|
Canto-Cetina T et al. |
Polymorphism of LRP5, but not of TNFRSF11B, is associated with a decrease in bone mineral density in postmenopausal Maya-Mestizo women. |
2013 Nov-Dec |
Am. J. Hum. Biol. |
pmid:24130145
|
Guerrini MM et al. |
Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations. |
2008 |
Am. J. Hum. Genet. |
pmid:18606301
|
Hocking LJ et al. |
Genomewide search in familial Paget disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10p13, and 5q35. |
2001 |
Am. J. Hum. Genet. |
pmid:11555792
|
Zagura M et al. |
Association of osteoprotegerin with aortic stiffness in patients with symptomatic peripheral artery disease and in healthy subjects. |
2010 |
Am. J. Hypertens. |
pmid:20224558
|
Noheria A et al. |
Association of serum osteoprotegerin with left ventricular mass in African American adults with hypertension. |
2010 |
Am. J. Hypertens. |
pmid:20339356
|
Ye Z et al. |
Associations of candidate biomarkers of vascular disease with the ankle-brachial index and peripheral arterial disease. |
2013 |
Am. J. Hypertens. |
pmid:23467205
|
Golledge J et al. |
A single-nucleotide polymorphism in the gene encoding osteoprotegerin is associated with diastolic blood pressure in older men. |
2009 |
Am. J. Hypertens. |
pmid:19779468
|
Nitta K et al. |
The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. |
2003 |
Am. J. Kidney Dis. |
pmid:12900812
|
Coen G et al. |
Serum leptin in dialysis renal osteodystrophy. |
2003 |
Am. J. Kidney Dis. |
pmid:14582047
|
Nitta K et al. |
Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis. |
2004 |
Am. J. Kidney Dis. |
pmid:15384019
|
Fukagawa M et al. |
Skeletal resistance to pth as a basic abnormality underlying uremic bone diseases. |
2001 |
Am. J. Kidney Dis. |
pmid:11576943
|
Sato T et al. |
Osteoprotegerin levels before and after renal transplantation. |
2001 |
Am. J. Kidney Dis. |
pmid:11576949
|
Kazama JJ et al. |
Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure. |
2002 |
Am. J. Kidney Dis. |
pmid:11877571
|
Haas M et al. |
Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients. |
2002 |
Am. J. Kidney Dis. |
pmid:11877577
|
Gottesman GS et al. |
Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget disease. |
2016 |
Am. J. Med. Genet. A |
pmid:26762549
|
Kantaputra PN et al. |
A newly recognized polyosteolysis/hyperostosis syndrome. |
2006 |
Am. J. Med. Genet. A |
pmid:17001672
|
Tanaka S |
Signaling axis in osteoclast biology and therapeutic targeting in the RANKL/RANK/OPG system. |
2007 |
Am. J. Nephrol. |
pmid:17652963
|
Mazzaferro S et al. |
Serum levels of calcification inhibition proteins and coronary artery calcium score: comparison between transplantation and dialysis. |
2007 |
Am. J. Nephrol. |
pmid:17259697
|
Cozzolino M et al. |
Vascular calcification and uremia: what do we know? |
2008 |
Am. J. Nephrol. |
pmid:18046081
|
Nishiura R et al. |
Elevated osteoprotegerin levels predict cardiovascular events in new hemodialysis patients. |
2009 |
Am. J. Nephrol. |
pmid:18802328
|
Lewis JR et al. |
Elevated osteoprotegerin predicts declining renal function in elderly women: a 10-year prospective cohort study. |
2014 |
Am. J. Nephrol. |
pmid:24457210
|
Cianciolo G et al. |
Importance of vascular calcification in kidney transplant recipients. |
2014 |
Am. J. Nephrol. |
pmid:24819032
|
Bersinger NA et al. |
PAPP-A and osteoprotegerin, together with interleukin-8 and RANTES, are elevated in the peritoneal fluid of women with endometriosis. |
2006 |
Am. J. Obstet. Gynecol. |
pmid:16635455
|
Rhee EJ et al. |
The effects of C161-->T polymorphisms in exon 6 of peroxisome proliferator-activated receptor-gamma gene on bone mineral metabolism and serum osteoprotegerin levels in healthy middle-aged women. |
2005 |
Am. J. Obstet. Gynecol. |
pmid:15846185
|
Hong JS et al. |
Maternal plasma osteoprotegerin concentration in normal pregnancy. |
2005 |
Am. J. Obstet. Gynecol. |
pmid:16157103
|
Redlich K et al. |
Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis. |
2004 |
Am. J. Pathol. |
pmid:14742260
|
Wilkison M et al. |
Type 1 interferons suppress accelerated osteoclastogenesis and prevent loss of bone mass during systemic inflammatory responses to Pneumocystis lung infection. |
2012 |
Am. J. Pathol. |
pmid:22626807
|